Micro-Scope V16 QUATTRO Diagnostic Suite
for medicare beneficiaries, use healthcare common procedural coding system (hcpcs) code g0105 (colorectal cancer screening; colonoscopy on individual at high risk) or g0121 (colorectal cancer screening; colonoscopy on individual not meeting the criteria for high risk) as appropriate. cms developed the hcpcs codes to differentiate between screening and diagnostic colonoscopies in the medicare population. if polyps are removed, use the appropriate cpt code listed above and add modifier pt (colorectal cancer screening test; converted to diagnostic test or other procedure) to each cpt code for medicare. if modifier pt is not added to the cpt code submitted on the medicare claim, the colonoscopy with polypectomy will not be recognized as a screening service and the patient will be inappropriately billed.
a positive wmm test was defined as the presence of any motile trichomonads in the upper chamber of the wet mount. for the in-house pcr test, the target region in the parasite ribosomal dna was amplified using the primer pair; 5’-aagcaattatatggaaacgccttc-3’ and 5’-tgcagcgcatcaagcgaaag-3’. amplification was performed in 25ul reactions with dntps, taq polymerase, and mgcl2. the amplification products were subsequently electrophoresed on a 2% agarose gel and visualised under uv light after ethidium bromide staining. a positive test was defined as the presence of any band in the pcr products of 309bp. for tv culture, the swabs were inoculated in inpouch culture chambers and incubated in an upright position at 37c for up to 7days. microscopic examination of the culture chambers was performed on days 1, 2, 3, 5 and 7. bacterial vaginosis was confirmed by the presence of gram negative, colourless, non-sporulating, non-motile organisms. all analyses were performed by two laboratory technicians blinded to the clinical presentation and diagnosis of the participants. each swab was tested in duplicate for each diagnostic test.
example #2indication: colon screening; patient with positive fecal occult blood testpost-endoscopy finding: polyps of various sizesprocedure code: g0102 (average risk screening) for medicare or 45378-33 (diagnostic colonoscopy with modifier 33 indicating this is a preventive service) for commercial insurancediagnosis code: v76.51 (special screening for malignant neoplasms, colon) example #3indication: change in bowel habits, presenting for colon screeningpost-endoscopy findings: normal colonprocedure: colonoscopyprocedure code: 45378 do not append modifier 33 or pt, as this service was performed for a diagnostic, not screening, indication. example #4indication: change in bowel habits, presenting for colon screeningpost-endoscopy findings: polyps of various sizesprocedure: colonoscopyprocedure code: 45378 do not append modifier 33 or pt, as this service was performed for a diagnostic, not screening, indication. for medicaid beneficiaries, use the hcpcs code g0435 (colonoscopy without polypectomy) for screening and diagnostic procedures. the code g0435 can be used only if the polypectomy was not performed. cms developed the hcpcs codes to differentiate between screening and diagnostic colonoscopies in the medicare population. finally, use the total charges for the procedure, rather than the code. the total charges can be used for reimbursement purposes. to determine the total charges for the procedure, go to the micro-scope tab of the quattro diagnostic suite, then select a procedure code. next, enter the hcpcs code for the procedure, the colonoscopy endoscopist, the patient’s sex, date of birth, and race in the required fields. the micro-scope will calculate the charges based on the hcpcs code, procedure type, endoscopist, and patient’s sex, date of birth, and race. if the charges are calculated correctly, the operations button can be selected to view the results. 5ec8ef588b